Navigation Links
Bradmer to present at Rodman & Renshaw Healthcare Conference
Date:11/3/2008

TSX: BMR

TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced today that Dr. Alan M. Ezrin, President and Chief Executive Officer of the Company, will present a corporate update at Rodman & Renshaw 10th Annual Healthcare Conference, which is being held in New York City from November 10th - 12th at the New York Palace Hotel. Dr. Ezrin will provide an update on the Company's ongoing GLASS-ART(TM) Trial, a Phase III study evaluating Neuradiab(TM) as an adjunct therapy to the current standard of care for newly diagnosed glioblastoma multiforme (GBM). The presentation will take place on Wednesday, November 12th at 10:45am ET in the Kennedy I Room and Dr. Ezrin will be available for questions following his presentation.

About the GLASS-ART Trial (http://www.glassarttrial.com)

The Phase III GLASS-ART Trial derives its name from its description: GBM Locoregional Agent Survival Study - Antitenascin Radiolabeled antibody Therapy Trial. The study is designed to determine the survival benefit derived from, and safety of, adding Neuradiab to the current standard of care therapy, consisting of surgery, radiation and adjuvant chemotherapy (temozolomide), for patients diagnosed with primary glioblastoma multiforme. The randomized trial was initiated in July 2008 and will enroll up to 760 patients at leading treatment centers across the United States. Additional information on the trial can be found at http://www.glassarttrial.com or at http://www.clinicaltrials.gov and then by searching the term "Bradmer" or the study identifier NCT00615186.

About Neuradiab(TM)

Neuradiab is a monoclonal antibody, conjugated to radioactive iodine, used to treat gl
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bradmer announces management changes
2. Bradmer provides Phase III Neuradiab trial update and guidance
3. Bradmer to present at Rodman & Renshaw Healthcare Conference
4. Bradmer Medical Isotope Supply For Phase III Trial Secure
5. Bradmer announces additions to Scientific Advisory Board
6. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
7. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
8. Notice of Bradmer Pharmaceuticals Conference Call
9. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
10. Bradmer announces new additions to management team
11. Bradmer announces 2008 first quarter operational and financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 01, 2015 , ... September is Baby Safety Month, and Lightning Labels ... to keep little ones' safety top of mind at all times. , Sponsored by ... According to the JPMA's Baby Safety Zone website, this year's theme is A Room ...
(Date:8/31/2015)... ... 01, 2015 , ... The PT Outcomes Registry is an organized system for ... patients. The Registry is being developed by the American Physical Therapy Association (APTA). , ... be selected to contribute FOTO Outcomes measures as one of the primary global outcomes ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... ... been updated to include a wealth of information for specific translation services within ... great expertise and an incredible track record of successful work. , ITC Global ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... insurance, announced today their new “ InstantQuote ” tool, which summarizes all available ... easy-to-understand format. The technology tool is designed to help India Network members make ...
(Date:8/31/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... powered by Movestrong, has launched pre and postnatal fitness classes. , ... and Thursdays. The classes are called "The Mom Bod" and "Healthy Body, Healthy ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2
... cases of polio in Maharashtra have crashed the efforts of ... ,The health officials on a polio-eradication drive have detected a ... was found to be affected by the P1 strain of ... ,According to sources, the Chief Minister, Mr Vilasrao Deshmukh, and ...
... has once again offered a valuable insight for one of ... disease. // Red wine has always hogged a fair share ... and brain. A recent study seems to suggest that Red ... been looking for! ,The researchers, from Mount Sinai ...
... project that plans the top health investments for disease ... ministers from the Americas at the Pan American Health ... American Health Organization, vaccines, taxes on tobacco and condom ... improvement in developing countries. ,The recently released ...
... experimental drug discovered by researchers in New Zealand and developed ... effective // in extending lives of lung cancer patients ... that it is the first step in the fight against ... and the death rate increases every year. The rate of ...
... issue of JAMA says that initial research indicates that ... has little or no effect on CD4 cell count ... as to when antiretroviral therapy must begin., ,Depletion ... immunodeficiency virus (HIV) disease and a powerful predictor of ...
... October issue of Radiology says that a mathematical formula ... with 75 percent accuracy.// Researchers say this will allow ... 45 percent of women have different levels of bone ... to uncertainty as to how physicians should assess their ...
Cached Medicine News:Health News:Lung Cancer Drug effective in extending lives 2Health News:HIV RNA Level Seen As Little Value In Predicting Treatment 2Health News:Formula Predicts Osteoporotic Fracture Risk 2
(Date:8/31/2015)... 31, 2015 Pepperl+Fuchs, a world leader ... Corporation, a leading provider of HART protocol devices. ... further extend its integrated solutions offerings and strengthen ... "We are pleased to add the MACTek ... Jim Bolin , Pepperl+Fuchs, executive vice president ...
(Date:8/31/2015)... , Aug. 31, 2015  Ascendant Solutions, Inc. ... today announced that its Healthcare subsidiary, Dougherty,s Holdings, has ... on the downtown square of Springtown, Texas ... than 35 years, this community-based pharmacy has provided retail ... of Springtown . The ...
(Date:8/31/2015)... 2015  Daktari Diagnostics today announced a collaboration with Merck, ... and Canada , to develop Daktari,s ... up to $8.5 million over the next 3.5 years, will ... regulatory approval of Daktari,s HCV test. The ... can detect low levels of virus directly in a single ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3
... grounds, direct programming is superior,to cloning as a ... Nov. 20 Two major scientific,papers published this ... way to,generate patient-matched human pluripotent stem cells without ... or human or animal eggs.,Research groups in Wisconsin ...
... 20 The following statement,was released today by ... the Elizabeth Glaser Pediatric AIDS Foundation:, "Four ... Relief,(PEPFAR) began funding treatment and prevention, today,s report ... remains a devastating worldwide,pandemic, we are beginning to ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need 2
Alcon offers medical grade perfluoropropane (C3F8) intraocular gases for ophthalmological use....
Round knurled handle. Overall length 130 mm....
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: